HbA2 Leuven and Its Impact on HbA1c Results

Universitaire Ziekenhuizen KU Leuven

Status: Completed

Conditions: Family Study HbA2 Leuven Mutation.

Treatments: Genetic: Blood withdrawal

Study type: Interventional

Funder types: Other

Identifiers

NCT01909648

S55709 (Other Identifier)

Details and patient eligibility

About

The study is designed to demonstrate HbA2 Leuven mutation and to asssess its impact on routine HbA1c measurements.

Full description

HbA2 Leuven mutation will be investigated using molecular diagnostic techniques.

Interference on HbA1c measurements will be assessed in HbA2 Leuven carriers using different methodologies.

Enrollment: 10 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Family history of HbA2 Leuven mutation.

Exclusion criteria

• Any condition inhibiting simple blood withdrawal.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

HbA2 Leuven

Other group

Description:

Presence of HbA2 Leuven mutation, demonstrated by molecular diagnosis on blood sample.

Treatment:

Genetic: Blood withdrawal

Genetic: Blood withdrawal